Radiopharmaceutical Laboratory Services (RLS) MAMC

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

W40M MRCO PACIFIC

Contract Value

Not provided

Codes & Classification
Solicitation Number

W81K0226QA015

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

NONE

Place of Performance

Tacoma, Washington, UNITED STATES

SourceSAM
Documents5
The Department of Defense, through the Department of the Army and its contracting office W40M MRCO PACIFIC, has issued a Combined Synopsis/Solicitation for Radiopharmaceutical Laboratory Services (RLS) to support the Madigan Army Medical Center (MAMC) in Tacoma, Washington. This procurement seeks qualified vendors capable of providing pharmaceutical preparation manufacturing services, specifically radiopharmaceutical laboratory products, as classified under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing) and Product Service Code 6505. The scope of this solicitation encompasses the supply and delivery of radiopharmaceutical products required for medical diagnostics and treatment at MAMC. The intended outcome is to ensure the medical center has reliable access to high-quality radiopharmaceuticals that meet clinical needs and regulatory standards. The procurement is designed to support ongoing patient care and medical operations at the facility. Key requirements and objectives include adherence to the updated quantities and product specifications as outlined in the solicitation amendments. Amendment 0001 revised the quantities for certain Contract Line Item Numbers (CLINs), resulting in changes to the products required for those CLINs. Vendors are instructed to use the conformed copy of the solicitation (Solicitation Amendment - W81K0226QA0150001 Conformed Copy) when preparing their quotes to ensure compliance with the latest requirements. Amendment 0002 further modified the solicitation by removing the Salient Characteristics, specifically eliminating the requirement for Joint Commission accreditation. This change broadens the pool of eligible vendors, allowing those who may not hold this accreditation to participate. Additionally, the response deadline was updated to 10:00 AM Pacific Time on January 23, 2026. There are no set-aside requirements for this procurement, meaning it is open to all qualified sources regardless of business size or socioeconomic status. The place of performance is Tacoma, Washington, and the contract will be administered by the federal contracting office W40M MRCO PACIFIC. Interested contractors should note that the solicitation is active and accessible via SAM.gov (Opportunity ID: 0a7716edd61c4b579f38dcfb8bc8067b). The notice includes five attachments, which likely contain the full solicitation details, amendments, and instructions for submission. All communications and inquiries regarding this opportunity should be directed to the designated contacts: Cindy Means ([email protected]) and Scott Barr ([email protected]). In summary, this procurement represents an opportunity for vendors specializing in pharmaceutical preparation manufacturing, particularly those with experience in radiopharmaceuticals, to support a major military medical facility. The requirements and deliverables are clearly defined in the solicitation and its amendments, and the absence of set-aside restrictions allows broad participation. Contractors should carefully review all solicitation documents and amendments to ensure their proposals are fully compliant and responsive to the government’s needs.